Psilocybin: Next to treat depression, OCD and nicotine addiction
Alcoholism & Drug Abuse Weekly September 24, 2021 DOI: 10.1002/adaw.33204 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Historical analysis Peer reviewed |
|---|---|
| Topics | Addiction Cannabis Psilocybin Depression |
| Keywords | Nicotine addiction Advertising |
| Key points | Argues that the marijuana industry lobbied to restrict home cultivation in legalized states to maintain profitability by creating artificial scarcity. |
Abstract
First it was the plant, cannabis. How could this be made into a saleable profit‐making commodity when it grows in the ground? Witness the marijuana (a chemical from the plant) industry, which lobbied to make sure laws in states that legalized it banned people from growing more than a few plants.
Comparable studies
Other theoretical and historical papers on cannabis for addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Aleister Crowley on Drugs | 2017 | Historical analysis | |
| High hopes? Precision psychedelic addiction medicine | 2025 | Theoretical or philosophical paper |